EP0449958B9
(en)
*
|
1988-12-19 |
2003-05-28 |
American Cyanamid Company |
Meningococcal class 1 outer-membrane protein vaccine
|
US7118757B1
(en)
|
1988-12-19 |
2006-10-10 |
Wyeth Holdings Corporation |
Meningococcal class 1 outer-membrane protein vaccine
|
CU22302A1
(es)
*
|
1990-09-07 |
1995-01-31 |
Cigb |
Secuencia nucleotidica codificante para una proteina de la membrana externa de neisseria meningitidis y uso de dicha proteina en preparados vacunales
|
PT624376E
(pt)
|
1993-05-13 |
2000-07-31 |
American Cyanamid Co |
Preparacao e utilizacoes de proteinas de membranas externas deficitarias em los de cocos gram-negativos
|
US6287574B1
(en)
|
1995-03-17 |
2001-09-11 |
Biochem Pharma Inc. |
Proteinase K resistant surface protein of neisseria meningitidis
|
HUP9901577A3
(en)
*
|
1995-09-18 |
2000-03-28 |
Lowell Georg H Cote St Luc |
Improved methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
|
FR2751000B1
(fr)
|
1996-07-12 |
1998-10-30 |
Inst Nat Sante Rech Med |
Adn specifiques des bacteries de l'espece neisseria meningitidis, leurs procedes d'obtention et leurs applications biologiques
|
US6558677B2
(en)
*
|
1996-10-15 |
2003-05-06 |
Wendell D. Zollinger |
Vaccine against gram negative bacteria
|
RU2347813C2
(ru)
*
|
1997-11-06 |
2009-02-27 |
Чирон С.П.А. |
Антигены нейссерий
|
GB9726398D0
(en)
|
1997-12-12 |
1998-02-11 |
Isis Innovation |
Polypeptide and coding sequences
|
GB9808734D0
(en)
*
|
1998-04-23 |
1998-06-24 |
Smithkline Beecham Biolog |
Novel compounds
|
GB9808866D0
(en)
|
1998-04-24 |
1998-06-24 |
Smithkline Beecham Biolog |
Novel compounds
|
GB9810276D0
(en)
*
|
1998-05-13 |
1998-07-15 |
Smithkline Beecham Biolog |
Novel compounds
|
GB9811260D0
(en)
|
1998-05-26 |
1998-07-22 |
Smithkline Beecham Biolog |
Novel compounds
|
GB9823978D0
(en)
|
1998-11-02 |
1998-12-30 |
Microbiological Res Authority |
Multicomponent meningococcal vaccine
|
US10967045B2
(en)
|
1998-11-02 |
2021-04-06 |
Secretary of State for Health and Social Care |
Multicomponent meningococcal vaccine
|
CA2360609A1
(en)
*
|
1999-01-22 |
2000-07-27 |
Smithkline Beecham Biologicals S.A. |
Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof
|
CA2838395C
(en)
|
1999-05-19 |
2016-07-19 |
Novartis Vaccines And Diagnostics S.R.L. |
Combination neisserial compositions
|
GB9918319D0
(en)
|
1999-08-03 |
1999-10-06 |
Smithkline Beecham Biolog |
Vaccine composition
|
GB9929923D0
(en)
*
|
1999-12-17 |
2000-02-09 |
Baldwin Thomas J |
Antigen preparations
|
WO2002009643A2
(en)
*
|
2000-07-27 |
2002-02-07 |
Children's Hospital & Research Center At Oakland |
Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
|
GB0103170D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
GB0103171D0
(en)
|
2001-02-08 |
2001-03-28 |
Smithkline Beecham Biolog |
Vaccine composition
|
RU2355704C2
(ru)
*
|
2001-04-17 |
2009-05-20 |
Новартис Вэксинс Энд Диагностикс, Инк |
Моноклональное антитело, направленное против gna33 пептида, и его применение
|
CA2439428C
(en)
*
|
2001-04-17 |
2012-01-24 |
Chiron Corporation |
Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
IL145926A0
(en)
*
|
2001-10-15 |
2002-07-25 |
Mor Research Applic Ltd |
Peptide epitopes of mimotopes useful in immunomodulation
|
CU22983A1
(es)
*
|
2002-05-08 |
2004-09-09 |
Inst Finlay |
Composición vacunal contra las alergias y método para su obtención y empleo en el tratamiento de las mismas
|
US20040096461A1
(en)
*
|
2002-07-30 |
2004-05-20 |
Baxter Healthcare Corporation |
Chimeric multivalent polysaccharide conjugate vaccines
|
KR20050039839A
(ko)
|
2002-08-02 |
2005-04-29 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
Lgtb- 나이세리아 메닌기티디스로부터의 l2 및/또는l3 면역유형 리포올리고사카라이드를 포함하는 백신 조성물
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
AU2003288660A1
(en)
|
2002-11-15 |
2004-06-15 |
Chiron Srl |
Unexpected surface proteins in neisseria meningitidis
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
CU23313A1
(es)
|
2002-11-27 |
2008-09-25 |
Inst Finlay Ct De Investigacia |
Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios
|
PT2191844E
(pt)
|
2003-01-30 |
2014-06-04 |
Novartis Ag |
Vacinas injetáveis contra múltiplos serogrupos meningocócicos
|
US20040241190A1
(en)
*
|
2003-04-07 |
2004-12-02 |
Xenova Research Limited |
Vaccine preparations
|
RU2250113C2
(ru)
*
|
2003-06-04 |
2005-04-20 |
Институт биоорганической химии им. академиков М.М.Шемякина и Ю.А.Овчинникова Российской академии наук |
Способ приготовления бивалентной вакцины для профилактики менингококковой инфекции
|
GB0316560D0
(en)
|
2003-07-15 |
2003-08-20 |
Chiron Srl |
Vesicle filtration
|
GB0323103D0
(en)
|
2003-10-02 |
2003-11-05 |
Chiron Srl |
De-acetylated saccharides
|
CU23420A1
(es)
*
|
2003-12-30 |
2009-09-08 |
Univ De Cambridge |
Proteoliposomas y sus derivados como adyuvantes inductores de respuesta citotóxica y las formulaciones resultantes
|
GB0406013D0
(en)
|
2004-03-17 |
2004-04-21 |
Chiron Srl |
Analysis of saccharide vaccines without interference
|
GB0408977D0
(en)
|
2004-04-22 |
2004-05-26 |
Chiron Srl |
Immunising against meningococcal serogroup Y using proteins
|
GB0411387D0
(en)
|
2004-05-21 |
2004-06-23 |
Chiron Srl |
Analysis of saccharide length
|
GB0413868D0
(en)
|
2004-06-21 |
2004-07-21 |
Chiron Srl |
Dimensional anlaysis of saccharide conjugates
|
GB0416120D0
(en)
|
2004-07-19 |
2004-08-18 |
Health Prot Agency |
Stable compositions containing OMV's
|
GB0424092D0
(en)
|
2004-10-29 |
2004-12-01 |
Chiron Srl |
Immunogenic bacterial vesicles with outer membrane proteins
|
HUE033196T2
(en)
|
2005-01-27 |
2017-11-28 |
Children's Hospital & Res Center At Oakland |
GNA1870-based vesicle vaccines for broad-spectrum protection against diseases caused by Neisseria meningitidis
|
ATE462444T1
(de)
|
2005-06-27 |
2010-04-15 |
Glaxosmithkline Biolog Sa |
Immunogene zusammensetzung
|
GB0524066D0
(en)
|
2005-11-25 |
2006-01-04 |
Chiron Srl |
741 ii
|
GB0605757D0
(en)
|
2006-03-22 |
2006-05-03 |
Chiron Srl |
Separation of conjugated and unconjugated components
|
US7943352B2
(en)
|
2006-03-29 |
2011-05-17 |
Bacoustics, Llc |
Apparatus and methods for vaccine development using ultrasound technology
|
EP2007427A4
(en)
|
2006-04-11 |
2012-04-04 |
Yeda Res & Dev |
IMPROVED VACCINES WITH MULTIMETER HSP60 PEPTIDE SUPPORTS
|
WO2008095677A1
(en)
*
|
2007-02-07 |
2008-08-14 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Recombinant antigens of human cytomegalovirus (hcmv)
|
ES2532946T3
(es)
*
|
2008-02-21 |
2015-04-06 |
Novartis Ag |
Polipéptidos PUfH meningocócicos
|
CU20080215A7
(es)
|
2008-11-19 |
2012-06-21 |
Inst Finlay |
Vacunas unitemporales
|
CN102596240B
(zh)
|
2009-08-27 |
2015-02-04 |
诺华股份有限公司 |
包括脑膜炎球菌fHBP序列的杂交多肽
|
CN102917730A
(zh)
|
2009-10-27 |
2013-02-06 |
诺华有限公司 |
修饰的脑膜炎球菌fHBP多肽
|
EP2544712A1
(en)
|
2010-03-10 |
2013-01-16 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
CU20100083A7
(es)
|
2010-05-05 |
2012-06-21 |
Inst Finlay |
Tolerogenos adyuvados como vacuna de malaria
|
HRP20240965T1
(hr)
|
2010-08-23 |
2024-10-25 |
Wyeth Llc |
Stabilne formulacije antigena rlp2086 iz bakterije neisseria meningitidis
|
EP3549601B1
(en)
|
2010-09-10 |
2021-02-24 |
Wyeth LLC |
Non-lipidated variants of neisseria meningitidis orf2086 antigens
|
GB201015132D0
(en)
|
2010-09-10 |
2010-10-27 |
Univ Bristol |
Vaccine composition
|
CU20110202A7
(es)
|
2011-11-02 |
2013-12-27 |
Inst Finlay Ct De Investigación Producción De Sueros Y Vacunas |
Composición inmunogénica de polisacáridos planos adyuvados y las formulaciones resultantes
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
KR101784644B1
(ko)
|
2012-03-09 |
2017-10-11 |
화이자 인코포레이티드 |
수막염균 조성물 및 이의 사용 방법
|
EP2689775A1
(en)
|
2012-07-25 |
2014-01-29 |
Instituto Finlay, Centro de Investigacion-Produccion de vacunas y sueros |
Cochleate with only one mamp
|
ES2685894T3
(es)
|
2013-03-08 |
2018-10-15 |
Pfizer Inc. |
Polipéptidos de fusión inmunogénicos
|
KR20180099912A
(ko)
|
2013-09-08 |
2018-09-05 |
화이자 인코포레이티드 |
나이세리아 메닌지티디스 조성물 및 그의 방법
|
CN106661092B
(zh)
|
2014-02-28 |
2021-07-06 |
葛兰素史密丝克莱恩生物有限公司 |
修饰的脑膜炎球菌fHbp多肽
|
MX391027B
(es)
|
2015-02-19 |
2025-03-21 |
Pfizer |
Composiciones de neisseria meningitidis y metodos de la misma.
|
PE20191107A1
(es)
|
2017-01-31 |
2019-08-26 |
Pfizer |
Composiciones de neisseria meningitidis y metodos respectivos
|
RU2659948C1
(ru)
*
|
2017-03-14 |
2018-07-04 |
Федеральное государственное бюджетное научноеучреждение "Омский аграрный научный центр" (ФГБНУ "Омский АНЦ") |
Способ получения R-бруцеллёзной сыворотки на кроликах
|
CN110157767A
(zh)
*
|
2019-04-18 |
2019-08-23 |
金花企业(集团)股份有限公司 |
一种转移因子口服溶液生物活性测定方法
|
CN115605222A
(zh)
|
2019-09-27 |
2023-01-13 |
辉瑞公司(Us) |
脑膜炎奈瑟氏菌组合物及其方法
|